Analysts: AstraZeneca PLC (AZN)

AZN on New York Consolidated

73.91USD
26 Nov 2014
Price Change (% chg)

$0.25 (+0.34%)
Prev Close
$73.66
Open
$73.76
Day's High
$74.15
Day's Low
$73.65
Volume
620,809
Avg. Vol
1,933,455
52-wk High
$82.68
52-wk Low
$55.23

Search Stocks

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform 0.94 December 26 Nov 2014

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 1 1 0 0
(2) OUTPERFORM 0 0 0 0
(3) HOLD 3 3 4 4
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.50 2.50 3.00 3.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 3 6,913.33 7,085.00 6,800.00 6,530.00
Quarter Ending Mar-15 1 5,905.00 5,905.00 5,905.00 --
Year Ending Dec-14 5 26,314.70 26,497.00 26,183.00 24,433.00
Year Ending Dec-15 5 25,114.50 26,155.00 24,351.00 24,028.30
Earnings (per share)
Quarter Ending Dec-14 3 0.94 1.03 0.83 1.23
Quarter Ending Mar-15 1 1.12 1.12 1.12 --
Year Ending Dec-14 5 4.43 4.55 4.35 4.71
Year Ending Dec-15 5 4.22 4.29 4.18 4.51
LT Growth Rate (%) 1 0.70 0.70 0.70 -10.70

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-14 6,284.50 6,542.00 257.50 4.10
Quarter Ending Jun-14 6,245.00 6,454.00 209.00 3.35
Quarter Ending Mar-14 6,321.67 6,416.00 94.33 1.49
Quarter Ending Dec-13 6,911.33 6,844.00 67.33 0.97
Quarter Ending Sep-13 6,452.67 6,250.00 202.67 3.14
Earnings (per share)
Quarter Ending Sep-14 1.03 1.05 0.01 1.45
Quarter Ending Jun-14 1.09 1.30 0.21 18.91
Quarter Ending Mar-14 1.23 1.17 0.06 5.13
Quarter Ending Dec-13 1.22 1.23 0.01 1.23
Quarter Ending Sep-13 1.25 1.22 0.03 2.40

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-14 6,913.33 6,837.50 6,643.50 6,688.50 6,530.00
Quarter Ending Mar-15 5,905.00 6,090.00 6,090.00 6,090.00 --
Year Ending Dec-14 26,314.70 26,243.80 25,918.80 25,928.60 24,433.00
Year Ending Dec-15 25,114.50 24,252.90 25,323.70 25,453.40 24,028.30
Earnings (per share)
Quarter Ending Dec-14 0.94 0.95 0.92 0.93 1.23
Quarter Ending Mar-15 1.12 0.98 0.98 0.90 --
Year Ending Dec-14 4.43 4.43 4.40 4.39 4.71
Year Ending Dec-15 4.22 4.19 4.11 4.08 4.51

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-14 1 0 2 0
Quarter Ending Mar-15 0 1 0 1
Year Ending Dec-14 1 0 4 0
Year Ending Dec-15 2 1 2 3
Earnings
Quarter Ending Dec-14 0 1 1 1
Quarter Ending Mar-15 1 0 1 0
Year Ending Dec-14 0 1 2 2
Year Ending Dec-15 2 0 4 1

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: MarketLine (a Datamonitor Company)
$175.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks